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Amazonian snakeBothrops brazili is a snake found in the forests of the Amazonian region whose commercial therapeutic anti-
bothropic serum has low efﬁcacy for local myotoxic effects, resulting in an important public health problem in
this area. Catalytically inactive phospholipases A2-like (Lys49-PLA2s) are among the main components from
Bothrops genus venoms and are capable of causing drastic myonecrosis. Several studies have shown that the C-
terminal region of these toxins, which includes a variable combination of positively charged and hydrophobic
residues, is responsible for their activity. In this work we describe the crystal structures of two Lys49-PLA2s
(BbTX-II and MTX-II) from B. brazili venom and a comprehensive structural comparison with several Lys49-
PLA2s. Based on these results, two independent sites of interaction were identiﬁed between protein and
membrane which leads to the proposition of a new myotoxic mechanism for bothropic Lys49-PLA2s composed
of ﬁve different steps. This proposition is able to fully explain the action of these toxins and may be useful to
develop efﬁcient inhibitors to complement the conventional antivenom administration.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Bothrops brazili is a snake found in the forests of the Amazonian
region particularly in parts of Brazil, Colombia, Peru, Ecuador,
Venezuela, Guyana, Suriname and French Guiana [1]. The antivenom
access to these remote areas is very limited due to natural geographic
barriers, vast territory and lack of road infrastructure. Furthermore,
the commercial therapeutic anti-bothropic serum has low efﬁcacy
against this and other Amazonian snakes [2] resulting in an important
public health problem in this Latin American region. A recent study
estimates that at least 421,000 envenomings and 20,000 deaths by
ophidian accidents occur each year in the world; however, due to
poor statistic data mainly in Asia, Africa and Latin America, these
numbers can be as high as 1,841,000 envenomings and 94,000 deaths
[3]. It has also been shown that the mortality caused by snakebites is
much higher than that of several neglected tropical diseases, including
dengue hemorrhagic fever, leishmaniasis, cholera, schistosomiasis and
Chagas disease [4]. These studies led the World Health Organization
(WHO) to recognize the ophidian accidents as an important neglected
tropical disease and the International Society on Toxinology to create
the Global Snakebite Initiative [4] aiming to reduce snakebitemorbidityIB, UNESP, Cx. Postal 510, CEP
ights reserved.and mortality. In Latin America, snakes from the Bothrops genus are
responsible for approximately 80% of all ophidian accidents [5,6]
that cause problems associated with prominent local tissue damage
characterized by swelling, blistering, hemorrhaging and necrosis of
the skeletal muscle, which are developed rapidly after snakebite.
These effects may lead to permanent disability of the victims creating
economic and social problems [7,8].
An important component of snake venoms is the phospholipase A2,
an enzyme able to promote Ca2+-dependent hydrolysis of sn-2 acyl
group of membrane phospholipids, releasing free fatty acids and
lysophospholipids [9,10]. A subgroup of these proteins, known as
Lys49-phospholipase A2 (Lys49-PLA2s), is catalytically inactive due
to the lack of Ca2+ coordination related to the natural mutations
Asp49→ Lys and Tyr28→ Asn [11,12], although it conserves all other
catalytic related residues (such as His48, Tyr53, Asp99) [13]. This class
of proteins is very common in bothropic venoms and, despite of their
catalytic inactivity, they are capable to cause drastic local myonecrosis
that is not efﬁciently neutralized by regular antivenom administration
[7]. Several studies have shown that the segment 115–125 of the
C-terminal region, which includes a variable combination of positively
charged and hydrophobic residues, is responsible for the myotoxic
activity [14–17].
Lys49-PLA2s isolated from Bothrops genus snake venoms are dimeric
as shown by electrophoresis, spectroscopic [18], small angle X-ray
scattering [19], and dynamic light scattering experiments [12]. A
Table 1
X-ray data collection and reﬁnement statistics.
BbTX-II MTX-II
Unit cell (Å) a= b=56.4; c=129.1° a=39.0; b=71.4;
c=44.4; β=102.5°
Space group P3121 P21
Resolution (Å) 32.3–2.11 (2.19–2.11)a 20–2.08 (2.15–2.08)a
Unique reﬂections 13,825 (1363)a 13,752 (1365)a
Completeness (%) 96.07 (97.64)a 95.87 (95.25)a
Rmergeb 6.3 (49.0)a 12.9 (35.3)a
Mean I/σ (I) 14.40 (3.23)a 5.29 (1.78)a
Rcryst (%)c 19.36 19.27
Rfree (%)d 24.43 23.62
Number of non-hydrogen atomse
Protein 1788 1837
PEG molecules – 53
Sulfates – 24
Waters 191 251
RMS (bonds)e 0.004 0.004
RMS (angles)e 0.83 0.86
Average B-factor (Å2)e 47.50 28.90
Ramachandran favored (%)e 97 97
Ramachandran outliers (%)e 0 0
Clashscoref 5.30 8.63
MolProbity overall scoref 1.54 1.78
a Numbers in parenthesis are for the highest resolution shell.
b Rmerge =∑hkl(∑i(|Ihkl,i ≤ Ihkl N I)) /∑hkl,i b IhklN, where Ihkl,i is the intensity of an
individual measurement of the reﬂection with Miller indices h, k and l, and bIhklN is the
mean intensity of that reﬂection. Calculated for I≥ 3∑ (I).
c Rcryst =∑hkl(||Fobshkl|− |Fcalchkl||) / |Fobshkl|, where |Fobshkl| and |Fcalchkl| are the
observed and calculated structure factor amplitudes.
d Rfree is equivalent to Rcryst but calculated with reﬂections (5%) omitted from the
reﬁnement.
e Calculated with Phenix [29].
f Calculated with MolProbity [32].
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crystallographic Lys49-PLA2 structures [20]. Furthermore, the pH-
induced dissociation of the dimers showed an abolishment of their
ability to disrupt liposomes [21] and reduced approximately 50% of
their activity upon skeletal muscle cell and mature muscle tissue
[22]. In spite of the experimental consensus that Lys49-PLA2s present
a dimeric conformation, the inspection of their unit cells in the
crystallographic structures showed two different dimeric conformations
as possible “biological dimers”. The ﬁrst possibility is known as
“conventional dimer” which is formed by contacts between the tips
of β-wing segments and N-terminal α-helices from both monomers
being the “choice” for the ﬁrsts Lys49-PLA2 structures [13,20]. The
second possibility is known as “alternative dimer”, being identiﬁed
initially for Lys49-PLA2s complexed with suramin or α-tocopherol,
since this is the unique possible assembly for the binding mode of
these molecules [23,24]. Subsequently, bioinformatic analyses with all
bothropic Lys49-PLA2s indicate that this conformation is more stable
in solution because it presents a larger interfacial area and a smaller
free energy compared to the conventional dimer [24]. Furthermore,
small angle X-ray scattering experiments [19] also demonstrated
that the “alternative conformation” is more likely to occur in solution.
This alternative dimer is stabilized by contacts between the putative
calcium-binding loop and C-terminal regions, and its dimeric interface
is formed by the hydrophobic surfaces surrounding the entrance to
the His48 region [24].
In this work we describe the crystal structures of two Lys49-PLA2s
(BbTX-II and MTX-II) from B. brazili venom and a comprehensive
structural comparison with several Lys49-PLA2s. From this comparison,
we propose a newmyotoxic mechanism for bothropic Lys49-PLA2s that
is able to fully explain the action of these toxins.
2. Material and methods
2.1. Protein puriﬁcation, crystallization and X-ray data collection
Brazilitoxin II (BbTX-II) was isolated from B. brazili venom by a
single-step reverse phase HPLC as previously described [25]. MTX-II
was obtained by the fractionation of B. brazili venom on a CM-
Sepharose column (2 cm × 20 cm) as previously described [26]. Both
proteins have 121 amino acids as determined by mass spectrometry
experiments [25,26], and there areﬁve differences between their primary
sequences: i) Glu4Gln, Lys20Ala, Gln68Pro, Asn111Gly and Ala130Pro,
respectively for BbTX-II and MTX-II. Crystallization experiments were
performed using sparse-matrix method [27], as previously described
[28]. In this former article, MTX-II was called as MT-II. Basically, the
crystallization conditions for each proteins were (i) for BbTX-II, 30%
(w/v) polyethylene glycol 4000, 0.25M lithium sulfate and 0.1M Tris
HCl at pH 8.5 and (ii) for MTX-II, 30% (w/v) polyethylene glycol 8000,
0.25 M ammonium sulfate and 0.1 M sodium cacodylate at pH 6.5.
Crystals were grown at 291 K for approximately 3 weeks for both
proteins. X-ray diffraction data for all crystals were collected at a
wavelength of 1.435 Å using a synchrotron-radiation source (MX1
station, Laboratório Nacional de Luz Síncrotron, LNLS, Campinas,
Brazil) and a MAR CCD imaging-plate detector (MAR Research).
Crystals were mounted in nylon loops and ﬂash-cooled in a stream
of nitrogen gas at 100 K using no cryoprotectant. The data were
processed using HKL 2000 program [29].
2.2. Structure determination and reﬁnement
Table 1 shows data-collection and reﬁnement statistics. The crystal
structures were determined by molecular-replacement techniques
implemented in the program Phaser [30] using the coordinates of
piratoxin-I (PrTX-I; PDB ID 2Q2J), a Lys49-PLA2 isolated from Bothrops
pirajai venom, for BbTX-II and bothropstoxin-I (BthTX-I; PDB ID 3IQ3),
a Lys49-PLA2 isolated from Bothrops jararacussu venom complexedwith polyethylene glycol 4000, for MTX-II. The model choices were
based on the best values of ﬁnal translation function Z score (TFZ) and
log-likelihood gain (LGG) followed by an automated model building
using AutoBuild in Phenix software suite [31]. Despite the amino acid
sequence of MTX-II obtained by mass spectrometry has indicated a
Leu in position 125 [26], an electron density compatible to a Phe
was observed in our crystallographic data. This residue is also
present in the position 125 for other bothropic Lys49-PLA2s
and this substitution on the amino acid sequence of MTX-II
crystallographic structure does not interfere with the discussion of
this work (Sections 4.2 and 4.3) due tomaintenance of the hydrophobic
characteristic of both residues. The modeling processes were always
performed by manual rebuilding with the program Coot [32] using
electron density maps calculated with coefﬁcients 2|Fobs|–1|Fcalc|.
Themodels were improved, as judged by the free R-factor [33], through
rounds of crystallographic reﬁnement (positional and restrained
isotropic individual B-factor reﬁnement, with an overall anisotropic
temperature factor and bulk solvent correction) using Phenix [31].
The reﬁnement statistics for the ﬁnal models are shown in Table 1. In
the structure of BbTX-II, due to lack of electron density, side chains of
the following residues were excluded: Phe3 (monomer A), Lys16
(monomer B), Lys20 (B), Val31 (B), Leu32 (B), Lys36 (A, B), Lys53 (B),
Lys57 (A, B), Gln68 (A, B), Lys69 (A), Lys70 (A, B), Arg72 (A), Asn88
(B), Asn111 (A, B), Lys115 (A, B), Lys116 (A, B), His110 (A), Leu121
(A), Lys122 (A, B), Pro123 (B), Lys127 (A, B), and Lys129 (A). In the
structure of MTX-II, the side chains of the following residues were
excluded: Val31 (B), Lys36 (A), Lys53 (B), Lys69 (A, B), Lys70 (A),
Arg72 (B), Lys78 (A), Asn87 (A), Lys122 (A, B), Lys127 (A, B), and
Lys129 (A, B). The stereochemical qualities of the models were checked
with the Phenix and MolProbity programs [31,34]. The coordinates
were deposited in the Protein Data Bank (PDB) under the identiﬁcation
codes 4K09 (BbTX-II) and 4K06 (MTX-II).
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Molecular comparisons between the protomers of both structures
were performed using the Coot program [32] with only the Cα
coordinates. All ﬁgures were generated by PyMOL [35] and Coot [32]
programs. Analyses of the quaternary assemblies, interfacial contacts of
the crystallographic models and buried surface area of the hydrophobic
residues were performed using the online interactive tool PISA [36]
available at the European Bioinformatics Institute server (http://www.
ebi.ac.uk). Two different angles, θA (aperture angle) and θT (torsional
angle) were used to quantify the oligomeric changes between the apo
and complexed forms according to a model previously proposed [24]. In
this model, the coordinates (x,y,z) of Cα atoms from the α-helices h2
and h3 were used to deﬁne two vectors (A and B) whose scalar product
deﬁned the aperture angle (θA). The torsional angle (θT) is calculated by
using thenormal plane formedby the vectors A andB fromonemonomer
and the vector B from the other monomer.
2.4. Dynamic light scattering
The dynamic light scattering (DLS) measurements were performed
with lyophilized MTX-II at 291 K, dissolved in ultra-pure water at a
concentration of 3.5 mg mL−1 using the instrument DynaPro TITAN
(Wyatt Technology). Data were measured one hundred times and
results were analyzed with Dynamics v.6.10 software.
3. Results
3.1. Overall structures
Crystals of both proteins diffracted approximately at 2.1Å (Table 1)
and belonged to P3121 and P21 space groups for BbTX-II and MTX-II,
respectively. The reﬁnements converged to ﬁnal R values of 19.4%
(Rfree= 24.4%) and 19.3% (Rfree = 23.6%), respectively for BbTX-II and
MTX-II. The ﬁnal models present a stereochemical quality expected for
structures with the same resolution (Table 1). Both structures have
seven disulﬁde bridges in each monomer and present the followingFig. 1.Dimeric structures of BbTX-II (A) and MTX-II (B) showed as a cartoon representation. Th
and MTX-II structures (monomers A and B) highlighting the most important structural deviatistructural features: (i) an N-terminal α-helix; (ii) a “short” helix;
(iii) a Ca2+ binding loop; (iv) two anti-parallel α-helices (2 and 3);
(v) two short strands of anti-parallel β-sheet (β-wing); and (vi) a
C-terminal loop (Fig. 1), similarly to other class II PLA2s [11,13,20].
BbTX-II andMTX-II structures have twomolecules in the asymmetric
unit and present similar oligomeric structures, but only MTX-II presents
ligand molecules bound to it. The reﬁned MTX-II structure displays
three polyethylene glycol (PEG) 4000 ligands and ﬁve sulfate ions
(Fig. 1). Two PEG molecules establish a large number of hydrophobic
interactions along the hydrophobic channel of the molecule (Leu10,
Pro17, Val 31, Leu31 and Pro113) while the third one is exposed
to solvent and establishes hydrogen bonds with Lys7, Leu10, Glu11
and Gly14 residues. These molecules are positioned similarly to other
PEG molecules [12], alpha-tocopherol [24] and fatty acid [37,38] in
other Lys49-PLA2 structures. Five sulfate ions interact through water
molecules with Glu12 (A), Ser21 (B), Ile82 (A), Lys100 (A) and Ala130
(A) or directly by hydrogen bonds with Asn17 (A), Arg34 (A), Lys53
(A), Thr81 (A), Lys115 (A) and Arg118 (A). These ions are also positioned
similarly to other complexed Lys49-PLA2 structures, such as BthTX-I and
PrTX-I complexed with α-tocopherol [24], BthTX-I complexed with PEG
4000 [12] and Bn-IV, a Lys49-PLA2 isolated from Bothrops neuwiedi
venom, complexed with myristic acid [38].
3.2. Biological oligomeric assembly
Results of dynamic light scattering experiments at 291 K
(crystallization temperature) with MTX-II indicated a mean hydro-
dynamic radius (RH) of 2.6 nm with a polydispersity of 9.3%. This RH
value corresponds to a molecular weight of approximately 32 kDa and
is, thus, equivalent to a dimer, being similar to that obtained for other
Lys49-PLA2s previously studied [12].
The examination of unit-cell packing of the BbTX-II and MTX-II
structures using the PISA software [36] suggested that their dimeric
conformations are stable in solution and are similar to other bothropic
Lys49-PLA2s (Fig. 1A and B). These analyses also demonstrated that
the alternative dimer conformation has better values of complexation
signiﬁcation score (CSS), interface area and solvation free energy gaine PEGmolecules and sulfate ions are showed by sticks. (C) Cα superposition of the BbTX-II
ons between them.
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for both structures. The BbTX-II structure in the alternative dimer
conformation presents a complexation signiﬁcance score (CSS) of 0.1,
an interfacial area of 512.5 Å2 and ΔiG = −9.4 Kcal/mol, while for
the conventional dimer it presents a CSS of zero, interfacial area of
498.4 Å2 and ΔiG= 0.6 Kcal/mol. The MTX-II structure presents in the
alternative dimer conformation a CSS of 1.0, interfacial area of
524.5 Å2 and ΔiG = −12.4 Kcal/mol, while for the conventional
dimer conformation it presents a CSS of zero, an interfacial area of
the 380.3 Å2 and ΔiG = −1.3 Kcal/mol. These results strengthen
previously theoretical [24] and experimental studies [19,23,24],
indicating that the alternative dimer conformation is the most likely
biological dimer for bothropic Lys49-PLA2s.
3.3. Structural comparison of BbTX-II and MTX-II
Superposition between Cα atoms of the monomers A and B from
BbTX-II resulted in an RMS deviation of 0.97 Å while the same
superposition between MTX-II monomers resulted in 0.66 Å. Taking
into account the presence of PEG ligands bound to MTX-II structure
and that the BbTX-II structure is unbound to any ligand, these values
are comparable to other Lys49-PLA2s [24]. In this previous study a
pattern was observed for apo forms (proteins unbound to ligands),
which presented an RMSD of around 1.0 Å, while for complexed
structures these values are lower. Additionally, when the monomers
of BbTX-II are compared with those of the MTX-II (Table 2), it can be
observed that onemonomer (called hereinmonomer B) is more similar
to the equivalentmonomer of the other structure. Interesting, this feature
was also observed for BthTX-I bound to different ligands compared to its
apo structure [12].
The superposition between BbTX-II and MTX-II monomers (Fig. 1C)
shows that the main differences occur in four regions: putative Ca2+
binding loop (residues 29–34), loops before and after β-wing region
(residues 57–60 and 86–90) and C-termini (117–130); although the
major differences are between the C-terminal and the putative Ca2+
binding loop regions. These structural deviations were also found in
the Cα superposition between several Lys49-PLA2 structures [12,24]
and it may be due to higher ﬂexibility of these segments that reﬂects
on their highest B-factors values compared to other regions of the
proteins.
Regarding quaternary structure comparisons, it has been shown for
other Lys49-PLA2s that when any ligand (PEG, α-tocopherol, BPB, fatty
acid) is bound to the hydrophobic channel in at least one monomer,
oligomeric changes are induced and the protein adopts an active
conformation [24]. In order to characterize these conformational
changes observed for Lys49-PLA2s, a tridimensional conﬁguration
model has been proposed based on two angles: θT (torsional angle)
and θA (aperture angle) [24]. This model was established for the so-
called “alternative dimer” by the observation that the Lys49-PLA2s
complexed to any ligand present a rearrangement of the C-terminus of
one monomer that changes the symmetry between the monomers
aligning them in the sameplane. These angleswere calculated for several
complexed and apo Lys49-PLA2s and their oligomeric conformation
could be divided into two classes [24] which complexed structures
presented lower torsional and higher aperture angles compared to theTable 2
Superposition between protomers of BbTX-II andMTX-II crystallographic structures (RMS
deviations (Å) of Cα atoms).
BbTX-II MTX-II
A B A B
BbTX-II (A) – 0.97 1.03 1.11
BbTX-II (B) 0.97 – 0.45 0.72
MTX-II (A) 1.03 0.45 – 0.66
MTX-II (B) 1.11 0.72 0.66 –apo ones. Subsequently, other Lys49-PLA2s were solved [12,39] and
this pattern was also observed. In the case of BbTX-II and MTX-II, their
calculated angles are, respectively, θT = 59° and θA = 7° and θT = 41°
and θA=29° being in agreement with the proposed model. In addition,
it was previously observed that oligomeric changes induced by ligands
in the toxins switch the space groups of the crystals. All apo dimeric
Lys49-PLA2s solved to this date belong to P3121 space group while
all complexed dimeric Lys49-PLA2 belong to P21 or P212121 space
groups [12]. These changes were also observed in BbTX-II and MTX-II
structures that belong to P3121 and P21 space groups, respectively
(Table 1).4. Discussion
4.1. Cationic membrane-stabilization site
Sulfate ions are present in crystallization conditions for several
PLA2s, and in some cases, electron densitymaps compatible with sulfate
ionswere found and incorporated in these crystallographic structures. It
has been suggested, based in the crystal structure of porcine pancreatic
PLA2, that the interacting region between sulfate ions and PLA2s is the
same as where these proteins interact with membranes, since negative
bivalent ions could mimic the phosphatidyl group of an anionic lipid
bilayer [40,41]. In these structures, sulfates bind with positive
charged residues in each monomer and also by other closer-range
H-bonding interactions. According to these authors, the interaction
of these residues with anionic phosphatidyl groups leads the
enzymes to achieve their fully active conformation. These positions
are also equivalent to that occupied by the phosphate group of a
phospholipid in the structure of an Asp49-PLA2 from cobra-venom
complexed with a transition-state analog [42]. Furthermore, forms I
and II crystal structures of the ACL myotoxin (a Lys49-PLA2 from
Agkistrodon contortrix laticinctus) [43] and zhaoermiatoxin structure
from Zhaoermia mangshanensis [44] presented sulfate ions bound to
Arg and Lys residues.
Similarly, the presence of sulfate ions interacting with positive
charged residues (Lys20, Arg34, Lys53, Lys115 and Arg118) in other
complexed Lys49-PLA2s, such as BthTX-I and PrTX-I complexed to
α-tocopherol [24], BthTX-I complexed to PEG 4000 [12] and Bn-IV, a
Lys49-PLA2 isolated from B. neuwiedi venom, complexed to myristic
acid [38] was reported. These structures are in active form because
there are ligands bound at their hydrophobic channel leading the
alignment of Lys20, Lys115 and Arg118 residues in the same plane
(side-by-side) [24]. Sulfate ion interactions with Arg34 and Lys53
seem to be only the result of weak interactions between these ions
and superﬁcial positively charges, since they establish at most two
hydrogen bonds with only Arg34 or with Lys53 and never are hydrogen
bonded with both residues at the same time. Finally, there are no
experimental evidences that support any physiological relevance for
the sulfate binding in these residues. In contrast, the basic cluster
formed by Lys20, Lys115 and Arg118was proposed to be the “myotoxic
site” of bothropic Lys49-PLA2s [24] because scanning alanine site-
directed mutagenesis showed a reduction in membrane damaging
activity against liposomemembranes for Lys115Ala [45] and Arg118Ala
[17] mutants of BthTX-I, a Lys49-PLA2 from B. jararacussu venom. The
structure of the MTX-II complexed to PEG (this work) presents sulfate
ions interacting with the residues Lys115 and Arg118 and establishes
a large number of interactions (Fig. 2). However, the interaction with
Lys20 is absent due to the natural mutation Lys20Ala, indicating that
the occurrence of a charged residue in position 20 is not essential for
the establishment of the myotoxic activity mechanism previously
proposed. The comparison between MTX-II complexed to PEG and
BbTX-II structures reveals that the binding of sulfate ions leads to a
major extension in solvent direction of Lys115 and Arg118 residues
(Fig. 3).
Fig. 2. Interaction of residues Lys20, Lys115 and Arg118with sulfate ions in different bothropic Lys49-PLA2 crystallographic structures. (A)MTX-II from Bothrops brazili venom complexed
with PEG 4000 (thiswork) (PDB ID4K06); (B) Bn-IV from Bothrops neuwiedi venom complexedwithmyristic acid [38] (PDB ID3MLM); (C) PrTX-I from Bothrops pirajai venom complexed
with α-tocopherol [24] (PDB ID 3CYL). The subscript numbers 1 and 2 refer to monomer A and B, respectively.
Fig. 3. Structural comparison betweenmembrane-docking site (MDoS) (A) and membrane-disruption site (MDiS) (B) regions fromMTX-II complexed to PEG 4000 (Lys49-PLA2 in active
form; yellow structure) and BbTX-II (Lys49-PLA2 in inactive form; cyan structure) structures. Subscript numbers 1 and 2 refer tomonomers A and B, respectively. Lys115, Arg118, Leu121,
and Phe125 residues and sulfate ions are represented by sticks.
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we suggest that this cluster of positive charged residues would be
responsible for the toxin “docking” with the phosphatidyl group of
anionic lipid bilayer membranes Then, we propose to call this cationic
cluster for the Lys49-PLA2s as “cationic membrane-docking site”
(MDoS) which is mainly formed by C-terminus residues (Lys115 and
Arg118), but is also aided by other positive and exposed residues such
as Lys20, Lys80, Lys122 and Lys127.4.2. Hydrophobic membrane-disruption site
Based on a crystallographic study with the ACL myotoxin, Ambrosio
and colleges [43] proposed that speciﬁc hydrophobic residues (Phe121
and Phe124) present in the C-terminal region of this toxin and other
Lys49-PLA2s would be related to their myotoxic activity. In the active
form of this structure, Phe121 and Phe124 have their aromatic rings
with parallel conformations and salient from the toxin surface forming
a contiguous patch resembling a hydrophobic knuckle. This hydrophobic
knuckle is only observed when the Lys122 residue interacts with the
Cys29\Gly30 peptide bond andwhen a ligand is bound to hydrophobic
channel of toxin. Similarly, BbTX-II and MTX-II structures also present
hydrophobic residues on the C-terminal region as observed in ACL
myotoxin structure [43]. However, in the case of BbTX-II and MTX-II,
Lys122 side chains were not modeled due the lack of electron densities
in their structures, a fact already observed for other Lys49-PLA2s
that, apparently, have random conﬁgurations in the majority of
Lys49-PLA2s [12]. Thus, the conformational changes suffered by the
C-terminus hydrophobic residues seem to be due to ligand binding
in the hydrophobic channel. Sequence alignment of Lys49-PLA2
C-termini shows a high level of hydrophobic residues in this portion,
particularly Leu, Pro and Phe in the positions 121, 124 and 125
(Fig. 4). In the case of bothropic Lys49-PLA2s, the positions 121 and
125 are always occupied by hydrophobic residues, where Leu and
Phe occur for 98% of the sequences. In addition, the side chains of
these residues from both monomers are approximately in a symmetricFig. 4. C-terminal amino acid alignment of Lys49-PLA2s deposited in NCBI Protein Data
Bank. The numbers upside the alignment correspond to positions 121 and 125 (according
to numeration proposed by Renetseder et al. [63] from the bovine pancreatic PLA2, which
contains 131 residues). The program AMAP v. 2.2 performed the alignment [64]. The
sequences isolated from snakes from Bothrops genus are highlighted. MTX-II: Lys49-PLA2
from Bothrops brazili venom (manually extracted from Costa et al. [26]); BbTX-II:
Braziliantoxin-II from B. brazili venom (manually extracted from Huancahuire-Vega et al.
[26]); PrTX-I: piratoxin-I from Bothrops pirajai venom (NCBI GI: 17433154); PrTX-II:
piratoxin-II from Bothrops pirajai venom (NCBI GI: 17368328); BthTX-I: bothropstoxin-I
from Bothrops jararacussu venom (NCBI GI: 51890398); BnSP-7: Lys49-PLA2 from Bothrops
pauloensis venom (NCBI GI: 239938675); MjTX-I: myotoxin-I from Bothrops moojeni
venom (NCBI GI: 17368325); MjTX-II: myotoxin-II from Bothrops moojeni venom (NCBI
GI: 62738542); BnIV: Lys49-PLA2 from B. pauloensis venom (NCBI GI: 333361256); BaTX:
Lys49-PLA2 from Bothrops alternatus venom (NCBI GI: 292630846); blk-PLA2: Lys49-PLA2
from Bothrops leucurus venom (NCBI GI: 353678055); PLA2K49: Lys49-PLA2 from Bothrops
andianus venom (NCBI GI: 442738889); M1-3-3: Lys49-PLA2 from Bothrops asper venom
(NCBI GI: 6492260); Myo-II: myotoxin-II from B. asper venom (BaspTX-II); Myo-IV:
Lys49-PLA2 from B. asper venom (NCBI GI: 166216293); MyoI: Lys49-PLA2 from Bothrops
atrox venom (NCBI GI: 82201805); GodMT-I: Lys49-PLA2 from Cerrophidion godmani
venom (NCBI GI: 4330040); GodMT-II: Lys49-PLA2 from C. godmani venom (NCBI
GI: 3122600); Acutohemo: acutohemolysin from Deinagkistrodon acutus venom
(NCBI GI: 26397573); DAV-K49: Lys49-PLA2 from Calloselasma rhodostoma venom
(NCBI GI: 27151658); Anum-1: Lys49-PLA2 from Atropoides nummifer venom (NCBI GI:
17433156); Cax-K49: Lys49-PLA2 from Crotalus atrox venom (NCBI GI: 26397690); APP-K-
49: Lys49-PLA2 from Agkistrodon piscivorus piscivorus venom (NCBI GI: 129478); BP-I:
Lys49-PLA2 from Trimeresurus ﬂavoviridis venom (NCBI GI: 408407670); BP-II: Lys49-PLA2
from T. ﬂavoviridis venom (NCBI GI: 408407672); BP-III: Lys49-PLA2 from T. ﬂavoviridis
venom (NCBI GI: 408407673); Ts-K49: Lys49-PLA2 from Viridovipera stejnegeri venom
(NCBI GI: 8220134); Bsc-K49: Lys49-PLA2 from Bothriechis schlegelii venom (NCBI GI:
25453450); R6-K49: Lys49-PLA2 from C. godmani venom (NCBI GI: 59727050); Tpu-K49:
Lys49-PLA2 from Trimeresurus puniceus venom (NCBI GI: 123916279); ACL-MT-1:
Lys49-PLA2 from Agkistrodon contortrix laticinctus venom (NCBI GI: 1352702); and Tbo-
K49: Lys49-PLA2 from Trimeresurus borneensis venom(NCBI GI: 123907684). The Bothrops
pauloensis species was recently reclassiﬁed as Bothropoides pauloensis [62].alignment (Fig. 5) after the ligand binding in hydrophobic channel on all
complexed bothropic Lys49-PLA2s.
Chioato and colleagues [17] performed site-directed mutagenesis
experimentswhich demonstrated a strong reduction of myotoxic activity
(measured by release of creatine kinase) and membrane damaging on
liposomemembranes of the Phe125Alamutant for BthTX-I. These authors
also showed that Phe125Trp mutant has the same level of membrane
damaging on liposome membranes for BthTX-I [17], reinforcing the
importance of a hydrophobic residue in this position for myotoxic
activity. Indeed, results of site-directed mutagenesis with aromatic
residues performed by the same group [45] suggest that the 115–119
region of protein interacts superﬁcially with the membrane, allowing
residues closed to position 125 to be partially inserted into the
membrane. Experiments using C-terminal synthetic peptides also
demonstrated that a hydrophobic residue in position 121 for the
expression of myotoxic activity [16] is essential.
Interestingly, the comparison of the hydrophobic cluster buried
surface areas between apo and complexed structures (inactive and
active states, respectively) obtained by the analysis with the PISA
Fig. 5. Localization ofMDoS (membrane-docking site) andMDiS (membrane-disruption site) on crystallographic structures of (A)MTX-II fromBothrops brazili venomcomplexedwith PEG
4000 (this work) (PDB ID 4K06); (B) Bn-IV from Bothrops neuwiedi venom complexed with myristic acid [38] (PDB ID 3MLM); (C) PrTX-I from Bothrops pirajai venom complexed with
α-tocopherol [24] (PDB ID 3CYL) and (D) ecarpholin S, a Ser49-PLA2 from Echis carinatus venom complexed with lauric acid [51] (PDB ID 2QHD).
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BPB, fatty acid) reduces the buried surface areas of Leu121 and
Phe125 (Table 3). This reduction occurs mainly due to oligomeric
changes of the Leu121 side chain after ligand binding, leading to a
decrease in approximately 70% of its buried surface area. Structural
comparison between MTX-II and BbTX-II Leu121 and Phe125 amino
acids reveals that the presence of a ligand in hydrophobic channel
(PEG 4000 in MTX-II structure) also leads to a major exposure of
these hydrophobic residues (Fig. 3). According to hydrophobicity scales
suggested by different authors [46,47] both Leu and Phe are among the
residues with higher hydrophobic indices. Furthermore, Leu and Phe
have the higher membrane permeability coefﬁcients [48], with their
bilayer permeability being up to 100 times higher in relation to charged
amino acids [49].Table 3
Buried surface area (BSA) of residues that constitute the hydrophobic membrane-
disruption site (MDiS; Leu-121 and Phe125). BthTX-I: bothropstoxin I from Bothrops
jararacussu venom [12] (PDB ID: 3HZD); PrTX-I: piratoxin I from Bothrops pirajai venom
[24] (PDB ID: 2Q2J); BbTX-II: brazilitoxin II from Bothrops brazili venom (this work)
(PDB ID 4K09); BnSP-7: a Lys49-PLA2 from Bothrops pauloensis venom [60] (PDB ID
1PA0); BthTX-I-PEG4K: BthTX-I complexed with PEG 4000 [12] (PDB ID 3IQ3); BthTX-I-
αT: BthTX-I complexed with alpha tocopherol [24] (PDB ID 3CXI); BthTX-I-BPB: BthTX-I
chemically modiﬁed by p-bromophenacyl bromide (BPB) [12] (PDB ID 3HZW); PrTX-I-
αT: PrTX-I complexed with alpha tocopherol [24] (PDB ID 3CYL); PrTX-I-BPB: PrTX-I
chemically modiﬁed by p-bromophenacyl bromide (BPB) [61] (PDB ID 2OK9); MTX-II-
PEG4K: MTX-II from B. brazili venom complexed with PEG 4000 (this work) (PDB ID
4K06); BnIV-myristic acid: Bn-IV from Bothrops neuwiedi venom complexed with myristic
acid [38] (PDB ID 3MLM). The B. pauloensis species was recently reclassiﬁed as Bothropoides
pauloensis [62].
BSA of MDiS (Å2)
Apo structures BthTX-I 122.78
PrTX-I 126.38
BbTX-II 88.84
BnSP-7 109.58
Complexed structures BthTX-I-PEG4K 61.15
BthTX-I-αT 52.64
BthTX-I-BPB 47.68
PrTX-I-αT 42.54
PrTX-I-BPB 68.49
MTX-II-PEG4K 63.75
BnIV-myristic acid 66.49Consequently, considering the high conservation level, and the
structural and functional studies about the hydrophobic cluster (121
and 125 residues) in bothropic Lys49-PLA2s, we propose that this site
ismainly responsible for themembrane disruption after toxin anchorage
and we call it herein as “hydrophobic membrane-disruption site”
(MDiS).Membrane perturbationwould be the key toxic event, allowing
an uncontrolled inﬂux of ions (Ca2+ and Na+) that initiates a complex
series of degenerative effects on muscle ﬁber [50].
Similarly, structural analysis of other classes of PLA2-like, Ser49-PLA2s
[51], demonstrated the presence of particular MDoS (Section 4.1) and
MDiS. Two hydrophobic residues, Phe123 and Trp125, would form the
putative MDiS while Asn114, Lys115 and Lys116, and possibly, Lys127
would form the putative MDoS (Fig. 5). The buried surface area of
Phe123 and Trp125 is 38.23Å2, indicating a high exposition to the solvent,
similarly to MDiS region in Lys49-PLA2s.
4.3. Structural bases of the myotoxic mechanism for Lys49-PLA2s
Several hypotheses have been raised to address the membrane
damage process produced by Lys49-PLA2s. Although some propositions
point to a direct action of these proteins towards membrane receptors
[52–54], the major number of hypotheses is based on the direct action
of the Lys49-PLA2s in the target membrane by electrostatic interactions
[14,18,24,43,55,56]. The ﬁrst proposal was based on the fact that a
synthetic peptide formed by C-terminus residues (115–129) of the
toxin displayed heparin-binding and cytolytic activities, leading to the
hypothesis that this region is mainly responsible for the membrane
damage activity produced by Lys49-PLA2s [14]. Themolecularmodeling
of themonomeric ACL myotoxin from A. contortrix laticinctus suggested
that partially conserved residues in Lys49-PLA2s (K7, E12, T13, K16, and
N17) associated with some speciﬁc lysine residues (K78, K80, K116,
and K117) form a site that may be responsible for myotoxic activity
in these toxins [57]. Subsequently, spectroscopic and crystallographic
studieswith the BthTX-I showed that this proteinmay causemembrane
destabilizing activity by an oligomeric triggering process of the toxin
(open and closed conformations) using the conventional dimer assembly
[18]. During this process, the C-termini change their conformation
leading a transition in the membrane bound form that disrupts the
packing of the bilayer phospholipids, resulting in the loss of membrane
2779C.A.H. Fernandes et al. / Biochimica et Biophysica Acta 1834 (2013) 2772–2781integrity [18]. Subsequently, Lomonte et al. [55], based on the former
model [18], suggested that cationic residues from C and N-terminal
regions would establish initially weak electrostatic interactions with the
anionic sites of the membrane that would be further strengthened by
the contribution of hydrophobic and aromatic residues of the C-termini.
These residues may partially penetrate and disorganize the bilayer.
Site-directed mutagenesis experiments also highlighted the relevance
of the C-terminal region for expression of myotoxic activity, specially
the Tyr117\Lys122 segment [45]. Ambrosio et al. [43] based on
the crystallographic structure of ACL myotoxin (non-bothropic and
monomeric Lys49-PLA2), proposed that the interaction of the Lys122
with Cys29\Gly30 peptide bond when a ligand is bound to a
hydrophobic channel would form a hydrophobic knuckle that would be
responsible for membrane perturbation. Posteriorly, Bortoleto-Bugs
et al. [56], also using the conventional dimer conformation, hypothesized
that a region of the toxin called interfacial recognition site (IRS) binds
anionic phospholipids inducing conformational changes in the protein,
leading the exposition of hydrophobic surfaces that strengthen the
protein/membrane interaction. More recently, dos Santos et al. [24]
proposed a myotoxic mechanism based on the alternative dimer
conformation for Lys49-PLA2s, whose myotoxic sites presented in both
monomers are formed speciﬁcally by the cationic residues Lys20,
Lys115 and Arg118 that are aligned side by side in this protein
conﬁguration.
Thus, based on the previous propositions and the experimental
observations of this work, we suggest a new myotoxic mechanism
of bothropic Lys49-PLA2s where all residues involved in this action areFig. 6.Myotoxicmechanism of bothropic Lys49-PLA2s. An apo Lys49-PLA2 is activated by the ent
leading to a reorientation of a monomer, measured by “two angle model” [24]. This reorientatio
plane, exposed to solvent and in a symmetric position for both monomers. The MDoS region
residues with phospholipid head group. Subsequently, the MDiS region (Leu121; Phe125) destspeciﬁed. In our hypothesis, the alternative dimer is adopted as the
biological oligomeric conformation that would act on the following
steps (Fig. 6).
I) Entrance of a hydrophobic molecule (e.g. fatty acid) at the
hydrophobic channel leading to a reorientation of a monomer
which may be measured by the “two angle model” [24]. This
reorientation causes a transition between “inactive” and “active”
states, causing exposure to the solvent and alignment of both
MDoS and MDiS residues in the same plane, with a symmetric
position for both monomers. The fatty acid may come from
the lyses process of the membrane by Asp49-PLA2s, reinforcing
the synergism between Asp and Lys49-PLA2s in snake venom
action. Previous studies showed that membrane lesion happens
with a small amount of Lys49-PLA2 when the process occurs
in the presence of Asp49-PLA2s [54]. In addition, this step
justiﬁes the conservation of residues from the putative catalytic
site and hydrophobic channel for Lys49-PLA2s regarding to
their protein ancestry (catalytic PLA2s) [58] and, also indicates a
functional relationship between the “catalytic” and “myotoxic”
sites [24].
II) Stabilization of the toxin on the membrane by interaction of the
MDoS from both monomers and the phospholipid head group.
As discussed in Section 4.1, sulfate ions observed in several
PLA2 structures would mimic the phosphatidyl group of an
anionic lipid bilayer, and then the interaction between MDoS
and membrane is a feasible possibility.rance of a hydrophobicmolecule (e.g. fatty acid) at the hydrophobic channel of the protein
n aligns C-terminal andMDoS regions side-by-side and puts the MDiS region in the same
(Lys20; Lys115; Arg118) stabilizes the toxin on membrane by the interaction of charged
abilizes the membrane with penetration of hydrophobic residues.
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both monomers into the membrane. This insertion causes a
disorganization of the membrane, allowing an uncontrolled inﬂux
of ions (i.e. Ca2+ and Na+), and eventually triggering irreversible
intracellular alterations and cell death [50]. Furthermore, the cells
damaged release ATP into the extracellular environment, which
ampliﬁes the effect of these proteins [59]. These ATP molecules
bind to muscle P2X purinergic receptors and induce Ca2+ and
Na+ inﬂux and K+ efﬂux in cells that have not been directly
damaged by the proteins [59].5. Concluding remarks
Previously evolutionary studies demonstrated that all Lys49-PLA2s
isolated from Bothrops snakes nest in a monophyletic clade [58]. These
data support some unique characteristics for the bothropic Lys49-
PLA2s, such as the essential role of the dimer formation for expression
of myotoxic activity and a speciﬁc mechanism of action. Indeed, the
dimer dissociation causes a severe impact in its toxicity [21,22] and
the high conservation of the residues that constitute the MDoS [24]
and MDiS (Fig. 4) is observed in the bothropic proteins. However,
non-bothropic Lys49-PLA2s have a high level of conservation of Lys115
and other Lys residues (Lys80, Lys122, Lys127 and Lys28) which are
exposed to solvent and thus, could constitute an analogousMDoS region.
Furthermore, since hydrophobic residues of C-terminal regions have also
a high level of conservation among all Lys49-PLA2s (Fig. 4), then steps II
and III may be conserved among all Lys49-PLA2s.
In conclusion, we performed an extensive comparative structural
analysis of the BbTX-II and MTX-II from B. brazili snake venom with
other bothropic Lys49-PLA2s available in PDB in order to propose a
coherent hypothesis of themolecular events that led to their toxicity.
We propose a new myotoxic mechanism composed of ﬁve steps:
i) fatty acid binding, ii) oligomeric changes, iii) protein–membrane
docking, iv) membrane destabilization by penetration of hydrophobic
residues and v) uncontrolled inﬂux of ions and cell death. This
proposition may be useful to efﬁciently develop inhibitors that can
be used to complement the conventional antivenom administration,
thus preventing permanent injuries still caused by these proteins in
snakebite victims.
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